These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21563168)

  • 1. Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD008308. PubMed ID: 21563168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008309. PubMed ID: 21735428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008310. PubMed ID: 23076945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles.
    Shashikant BN; Miller TL; Welch RW; Pilon AL; Shaffer TH; Wolfson MR
    J Appl Physiol (1985); 2005 Dec; 99(6):2204-11. PubMed ID: 16081627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.
    Singh N; Halliday HL; Stevens TP; Suresh G; Soll R; Rojas-Reyes MX
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010249. PubMed ID: 26690260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.
    Levine CR; Gewolb IH; Allen K; Welch RW; Melby JM; Pollack S; Shaffer T; Pilon AL; Davis JM
    Pediatr Res; 2005 Jul; 58(1):15-21. PubMed ID: 15774846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008311. PubMed ID: 21412918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome.
    Wolfson MR; Funanage VL; Kirwin SM; Pilon AL; Shashikant BN; Miller TL; Shaffer TH
    Am J Perinatol; 2008 Nov; 25(10):637-45. PubMed ID: 18841530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Bahadue FL; Soll R
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cromolyn sodium for the prevention of chronic lung disease in preterm infants.
    Ng G; Ohlsson A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003059. PubMed ID: 28114736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.